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The first documented confirmed case of an imported fire ant causing anaphylaxis in Canada is herein reported. In a
patient with anaphylaxis to ants a physician in Canada should be aware that an allergic reaction to fire ant is a
possibility.Index case
A 43 year old female presented for allergy assessment in
December of 2012 having been bitten by several “red
ants” in a Toronto park in July of 2012. Her manifesta-
tions included immediate localized swelling at the bite
sites followed within minutes by generalized pruritus
and presyncope. She was taken to a local emergency and
treated with intravenous diphenhydramine, ranitidine,
and prednisone. It was unclear what the vitals were at
the time. Epinephrine was not given and her swelling
took a few days to resolve. Her past medical history was
significant for mild intermittent asthma and a morphine
anaphylaxis. Her physical exam in December 2012 was
unremarkable for any findings to suggest urticaria pig-
mentosa or dermographism.
At the time of the reaction there were no cofactors of
anaphylaxis including alcohol, non steroidal anti-
inflammatory use, exercise, or proton pump inhibitor
use. There were no confounding medications and no
prior history of latex or food allergies. Food was not
ingested for 4 hours prior to this. This patient is a trav-
eller to Florida and other southern states in the USA
but had not been there for at least 4 months.
The standard of care of skin prick testing to whole
body prepared fire ants was performed along with the
other five venom containing insects in Canada which in-
cludes white faced hornet, yellow jacket, yellow hornet,
honey bee, and wasp.
To the investigator’s surprise the whole body fire ant
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action with the positive control being 4 mm wheal and
negative skin prick test being 1 mm. The other venoms
of the vespids and aphids flying insects were negative at
a concentration up to 1 mcg /mL (ALK commercial ex-
tracts). Intradermal testing with fire ant was not done as
the skin prick test was clearly positive.
Discussion
Fire ants are endemic to southern and south eastern
United States [1] and thus far no previous reports of
anaphylaxis to fire ants have been documented in
Canada. Once considered simply an outdoor pest lim-
ited to a range of a few southern states in the USA, it
now appears to be a broader problem with anaphylaxis
reported in more northern states [1]. At this time it is
unclear the exact mortality rate due to venom from
imported fire ants and the extent of this problem in
North America.
Several interesting points come out of this fascinating
case. It is unclear exactly which factor, be it climate
change resulting in warmer winters in Southern Ontario,
globalization, or increased trafficking of exotic pets and
insects that this patient somehow managed to not only
find but have anaphylaxis to imported fire ants. Prior to
the winter of 2013 there were no prolonged freezes in
Southern Ontario. In fact the presence of fire ants in
Canada in multiple provinces and confirmed by Environ-
ment Canada has been reported in the Globe and Mail
going back to at least 2009 [2]. As physicians the local
changes to climate and environment are often overlooked.
Most allergists do not routinely have commercially pre-
pared fire ant allergen extracts but if this becomes more
of a common occurrence in the future certainly this indexntral Ltd. This is an Open Access article distributed under the terms of the
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cause of anaphylaxis.
It is also possible that there are issues of cross reactiv-
ity, however given that all other testing was negative and
the absence of scorpion bites in the patient’s history this
is unlikely but worthy of considering [3,4].
Moreover, the management of an emergency visit for
anaphylaxis should include the administration of adren-
aline. In fact this patient personally went out and
purchased an epinephrine auto-injector out of pocket
highlighting a common problem identified in earlier
studies in Canada [5] of inadequate emergency depart-
ment anaphylaxis action plans. In addition it was noted
that the patient initiated the consultation to an allergist
by specifically making the request instead of this being
part of a routine emergency protocol as is recommended
by the American Academy of Allergy Asthma and Im-
munology (AAAAI) [6] and by Canadian experts on the
subject. Admittedly the lack of initiating referrals to aller-
gists is a problem seen across the border with venom ana-
phylaxis [1,7]. The management would include carrying a
MedicAlert® bracelet identifying this allergy and also iden-
tifying the fact that this patient carries an EpiPEN® [8].
Furthermore, in anyone with a potential life threatening
anaphylaxis to venom with confirmed venom allergy
should undergo the standard of care which is
desensitization therapy to the venoms [1,6-8].
Conclusions
Consider reactions to imported fire ants occurring in
Southern Ontario as plausible. Routine testing for ana-
phylaxis in an outdoor setting with an insect may be ne-
cessary. We would welcome any other physicians who
have noticed this phenomena to contact us.
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